147 related articles for article (PubMed ID: 30087776)
1. A patient with a germline
Maher M; Roncaroli F; Mendoza N; Meeran K; Canham N; Kosicka-Slawinska M; Bernhard B; Collier D; Drummond J; Skordilis K; Tufton N; Gontsarova A; Martin N; Korbonits M; Wernig F
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 30087776
[TBL] [Abstract][Full Text] [Related]
2. An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline
Alzahrani AS; Bin Nafisah A; Alswailem M; Moria Y; Poprawski D; Al-Hindi H; Pacak K
Front Endocrinol (Lausanne); 2023; 14():1273093. PubMed ID: 38152133
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN
Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851
[TBL] [Abstract][Full Text] [Related]
4. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
Papathomas TG; Gaal J; Corssmit EP; Oudijk L; Korpershoek E; Heimdal K; Bayley JP; Morreau H; van Dooren M; Papaspyrou K; Schreiner T; Hansen T; Andresen PA; Restuccia DF; van Kessel I; van Leenders GJ; Kros JM; Looijenga LH; Hofland LJ; Mann W; van Nederveen FH; Mete O; Asa SL; de Krijger RR; Dinjens WN
Eur J Endocrinol; 2014 Jan; 170(1):1-12. PubMed ID: 24096523
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice.
Xekouki P; Szarek E; Bullova P; Giubellino A; Quezado M; Mastroyannis SA; Mastorakos P; Wassif CA; Raygada M; Rentia N; Dye L; Cougnoux A; Koziol D; Sierra Mde L; Lyssikatos C; Belyavskaya E; Malchoff C; Moline J; Eng C; Maher LJ; Pacak K; Lodish M; Stratakis CA
J Clin Endocrinol Metab; 2015 May; 100(5):E710-9. PubMed ID: 25695889
[TBL] [Abstract][Full Text] [Related]
6. Malignant paraganglioma and somatotropinoma in a patient with germline SDHB mutation-genetic and clinical features.
Saavedra A; Lima J; Castro L; Silva R; Macedo S; Rodrigues E; Carvalho D
Endocrine; 2019 Jan; 63(1):182-187. PubMed ID: 30155846
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M
J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863
[TBL] [Abstract][Full Text] [Related]
8. SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
Branzoli F; Salgues B; Marjańska M; Laloi-Michelin M; Herman P; Le Collen L; Delemer B; Riancho J; Kuhn E; Jublanc C; Burnichon N; Amar L; Favier J; Gimenez-Roqueplo AP; Buffet A; Lussey-Lepoutre C
Endocr Relat Cancer; 2023 Feb; 30(2):. PubMed ID: 36449569
[TBL] [Abstract][Full Text] [Related]
9. Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline
Santi R; Rapizzi E; Canu L; Ercolino T; Baroni G; Fucci R; Costa G; Mannelli M; Nesi G
Anticancer Res; 2017 Feb; 37(2):805-812. PubMed ID: 28179334
[TBL] [Abstract][Full Text] [Related]
10. Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours.
Loughrey PB; Roncaroli F; Healy E; Weir P; Basetti M; Casey RT; Hunter SJ; Korbonits M
Endocr Relat Cancer; 2022 Oct; 29(10):R157-R172. PubMed ID: 35938916
[TBL] [Abstract][Full Text] [Related]
11. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
[TBL] [Abstract][Full Text] [Related]
12. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.
MacFarlane J; Seong KC; Bisambar C; Madhu B; Allinson K; Marker A; Warren A; Park SM; Giger O; Challis BG; Maher ER; Casey RT
Clin Endocrinol (Oxf); 2020 Nov; 93(5):528-538. PubMed ID: 32686200
[TBL] [Abstract][Full Text] [Related]
13. Succinate dehydrogenase deficiency is rare in pituitary adenomas.
Gill AJ; Toon CW; Clarkson A; Sioson L; Chou A; Winship I; Robinson BG; Benn DE; Clifton-Bligh RJ; Dwight T
Am J Surg Pathol; 2014 Apr; 38(4):560-6. PubMed ID: 24625421
[TBL] [Abstract][Full Text] [Related]
14. Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ
Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry and Mutation Analysis of
Snezhkina AV; Kalinin DV; Pavlov VS; Lukyanova EN; Golovyuk AL; Fedorova MS; Pudova EA; Savvateeva MV; Stepanov OA; Poloznikov AA; Demidova TB; Melnikova NV; Dmitriev AA; Krasnov GS; Kudryavtseva AV
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971818
[TBL] [Abstract][Full Text] [Related]
16. Identification of succinate dehydrogenase-deficient bladder paragangliomas.
Mason EF; Sadow PM; Wagner AJ; Remillard SP; Flood TA; Belanger EC; Hornick JL; Barletta JA
Am J Surg Pathol; 2013 Oct; 37(10):1612-8. PubMed ID: 23797725
[TBL] [Abstract][Full Text] [Related]
17. Pituitary Carcinoma in a Patient with an SDHB Mutation.
Tufton N; Roncaroli F; Hadjidemetriou I; Dang MN; Dénes J; Guasti L; Thom M; Powell M; Baldeweg SE; Fersht N; Korbonits M
Endocr Pathol; 2017 Dec; 28(4):320-325. PubMed ID: 28284009
[TBL] [Abstract][Full Text] [Related]
18. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma.
Lussey-Lepoutre C; Bellucci A; Morin A; Buffet A; Amar L; Janin M; Ottolenghi C; Zinzindohoué F; Autret G; Burnichon N; Robidel E; Banting B; Fontaine S; Cuenod CA; Benit P; Rustin P; Halimi P; Fournier L; Gimenez-Roqueplo AP; Favier J; Tavitian B
Clin Cancer Res; 2016 Mar; 22(5):1120-9. PubMed ID: 26490314
[TBL] [Abstract][Full Text] [Related]
20. The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors.
Xekouki P; Brennand A; Whitelaw B; Pacak K; Stratakis CA
Horm Metab Res; 2019 Jul; 51(7):419-436. PubMed ID: 30273935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
